Silver Book Fact

The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with diabetic retinopathy is $493 million.

Rein D, Zhang P, Wirth K, Lee P, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, Lee P, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Global DR Prevalence
    The overall prevalence of global DR is 34.6%—6.96% for PDR, 6.81% for DME, and 10.2% for vision-threatening DR.  
  • Visual impairment and blindness cause an annual health utility loss of approximately $10.5 billion. This figure measures lost quality of life when a disease has little or no short-term impact…  
  • Estimated Direct Nonmedical Costs for People Who Are Visually Impaired or Blind  
  • From 2005 – 2008, around 4.2 million diabetics age 40 and older had diabetic retinopathy.  Of these, 655,000 had advanced diabetic retinopathy that could lead to severe vision loss.  
  • An estimated 1,288,275 Americans age 40 and older are blind.